1-methylcycloundecanecarbonitrile | 35664-91-6

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 1-methylcycloundecanecarbonitrile
• 英文别名: 1-Methylcycloundecane-1-carbonitrile
• CAS: 35664-91-6
• 化学式: C₁₃H₂₃N
• 分子量: 193.332
• InChiKey: BHSMAGWEVATODV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.92
• 拓扑面积：
  23.8
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  Cycloundecanecarbonitrile 、 硫酸二甲酯 生成 1-methylcycloundecanecarbonitrile
  参考文献：
  名称：

  Lorenz,P. et al., Chemische Berichte, 1971, vol. 104, p. 3429 - 3455

  摘要：

  DOI：

文献信息

• Thermodecarbonylation of α-substituted cycloalkanones: a convenient one-carbon ring contraction method
  作者：Georg Rüedi、Matthias A. Oberli、Hans-Jürgen Hansen

  DOI：10.1016/j.tetlet.2004.08.149

  日期：2004.10

  A new and very convenient one-carbon ring contraction method is reported. Pyrolysis of α-substituted cycloalkanones at 600–650 °C under flow conditions produces the ring contracted compounds under loss of carbon monoxide. Substrates varying in ring size and nature of the α-substituent have been investigated.

  报道了一种新的且非常方便的单碳环收缩方法。在流动条件下，α-取代的环烷酮在600–650°C的温度下热解，会在一氧化碳流失的情况下产生收缩的化合物。已经研究了环尺寸和α-取代基性质不同的底物。
• Radiation Curable Compositions
  申请人：Wang Zhikai Jeffrey

  公开号：US20110028641A1

  公开（公告）日：2011-02-03

  The present invention relates to composition comprising at least one compound obtained from the reaction of at least one compound (i) having a refractive index n D 20 of at least 1.50 comprising at least one isocyanate-reactable functional group-XH, wherein each of X is, independently, O or NR, at least one polyisocyanate (ii), and, optionally, at least one compound (iii) comprising at least one isocyanate-reactable functional group —YH and at least one curable functional group Q, wherein each of Y is, independently, O, NR or S, and its use for making high refractive index coatings and films.
• HETEROCYCLIC SUBSTITUTED-3-HETEROARYLIDENYL-2-INDOLINONE DERIVATIVE
  申请人：Boston Biomedical, Inc.

  公开号：US20190241550A1

  公开（公告）日：2019-08-08

  Disclosed is a compound represented by formula (1) or a pharmacologically acceptable salt thereof. (In the formula, R 1 is optionally substituted heteroaryl etc.; R 2 is hydrogen etc.; R 3 and R 4 are each independently hydrogen etc., R 5 is the following group: (wherein Y is optionally substituted five membered heteroaryl etc., R 9a is optionally substituted aryl etc., R 9b and R 9c are each dependently hydrogen etc., and m is the integral 0 etc.) etc.; R 6 is hydrogen etc.; and R 7 is hydrogen etc.
• MACROCYCLIC COMPOUNDS AS STING AGONISTS
  申请人：LUPIN LIMITED

  公开号：US20220144852A1

  公开（公告）日：2022-05-12

  Disclosed are the macrocyclic compounds having the general Formula (I) and their tautomeric forms, stereoisomers, pharmaceutically acceptable salts, and their combination with suitable medicament, corresponding processes for the synthesis and pharmaceutical compositions and uses of compounds disclosed herein.